Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-08-16 00:00:00 ET · period of report 2022-08-12 · accession 0001567619-22-016387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-16 | 2022-08-12+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale | $94.95 | -7,000 | 328.3K | -2% | -$664.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-12 | S | D | 4,000 | $94.75 | 331,324 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-15 | S | D | 3,000 | $95.21 | 328,324 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |